Bodycote Plc – Transaction in Own Shares

Bodycote Plc – Transaction in Own Shares

PR Newswire

[Bodycote]              www.bodycote.com

16 March 2026

Bodycote plc

Share Buyback Programme – Transactions in Own Securities

Bodycote plc (the Company) announces that in the week 9 March to 13 March 2026,
it purchased for cancellation the following number of its ordinary shares of
173/11 pence each (Ordinary Shares) through Barclays Bank plc, as part of the
first £40 million tranche of the £80 million share repurchase programme
announced on 11 March 2026 (the `Programme’).  All Ordinary Shares were purchase
from Barclays Bank plc as an `on exchange’ transaction subject to the rules of
the London Stock Exchange.

+———————————————–+——————+
|Dates of purchase: |11 – 13 March 2026|
+———————————————–+——————+
|Total number of ordinary shares purchased: |55,538 |
+———————————————–+——————+
|Highest price paid per share (pence per share):|750.00p |
+———————————————–+——————+
|Lowest price paid per share (pence per share): |665.50p |
+———————————————–+——————+
|Volume weighted average price paid per share |703.83p |
| | |
|(pence per share) | |
+———————————————–+——————+

Since the commencement of this Programme, the Company has purchased 55,538
Ordinary Shares in aggregate for cancellation from Barclays Bank plc in
accordance with the Programme. Following the above purchases and cancellation of
these Ordinary Shares, the Company will have 172,707,052 Ordinary Shares in
issue, with no shares held in treasury. This figure represents the total number
of voting rights.

This announcement is made in accordance with the requirements of UK Listing Rule
9.6.6.

In accordance with Article 5(1)(b) of the Market Abuse Regulation, a breakdown
of the individual trades made by Barclays as principal on behalf of the Company
in connection with the above purchases is detailed in the attachment. Purchases
made under Programme will be announced on a weekly basis.
260316 – Bodycote Buyback – Weekly
Transactions.pdf (https://mb.cision.com/Public/22491/4321366/af96085d746b2dda.pdf
)

For further information, please contact:

Bodycote plc

Jim Fairbairn, Chief Executive Officer

Ben Fidler, Chief Financial Officer

Peter Lapthorn, Head of FP&A and Investor Relations

Tel: +44 1625 505300

FTI Consulting

Richard Mountain

Edward Knight

Tel: +44 203 727 1340

This information was brought to you by Cision http://news.cision.com
The following files are available for download:
https://mb.cision.com/Public/22491/4321366/af96085d746b2dda.pdf 260316 – Bodycote Buyback – Weekly Transactions

contador

Publicidad